LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.53 | 21.74 | 3319 | 5150 | 0.6444 | 0.8916 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.53 | 21.74 | 3350 | 5150 | 0.6504 | 0.8939 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.53 | 21.74 | 3370 | 5150 | 0.6543 | 0.8953 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.53 | 21.74 | 237 | 5150 | 0.0460 | 0.3537 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.53 | 21.74 | 3864 | 5150 | 0.7502 | 0.9284 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.50 | 21.74 | 3446 | 5425 | 0.6351 | 0.8892 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.50 | 21.74 | 3490 | 5425 | 0.6432 | 0.8922 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.50 | 21.74 | 3473 | 5425 | 0.6401 | 0.8910 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.50 | 21.74 | 3502 | 5425 | 0.6454 | 0.8930 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.50 | 21.74 | 267 | 5425 | 0.0492 | 0.3702 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 53.50 | 21.74 | 4078 | 5425 | 0.7516 | 0.9296 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.48 | 21.74 | 3671 | 5768 | 0.6364 | 0.8908 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.48 | 21.74 | 3719 | 5768 | 0.6447 | 0.8939 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.48 | 21.74 | 3688 | 5768 | 0.6393 | 0.8919 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.48 | 21.74 | 3704 | 5768 | 0.6421 | 0.8929 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.48 | 21.74 | 318 | 5768 | 0.0551 | 0.3954 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 55.48 | 21.74 | 4275 | 5768 | 0.7411 | 0.9269 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 57.45 | 21.74 | 3891 | 6023 | 0.6460 | 0.8951 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 57.45 | 21.74 | 3930 | 6023 | 0.6524 | 0.8975 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 57.45 | 21.74 | 3884 | 6023 | 0.6448 | 0.8947 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 57.45 | 21.74 | 3903 | 6023 | 0.6480 | 0.8959 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 57.45 | 21.74 | 332 | 6023 | 0.0551 | 0.3993 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 57.45 | 21.74 | 4551 | 6023 | 0.7555 | 0.9321 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 59.42 | 21.74 | 4156 | 6125 | 0.6785 | 0.9069 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 59.42 | 21.74 | 4197 | 6125 | 0.6852 | 0.9092 | MN20160310_N01 | E20 |